Monthly Archives: May 2010
New FDA Campaign Targets Detailing, Trade Shows
In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Posted in FDA, News, Regulatory Tagged Advertising, DDMAC, Detailing, FDA, Margaret Hamburg, Marketing, Professional Marketing Leave a comment
Judgment Day for Pfizer Factories
For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015.
In 2006, the company announced plans to save $4 billion to $5 billion, and after [...]
Posted in Europe, Global, Manufacturing, News, Strategy Tagged Cuts, exit strategies, injectables, Ireland, Manufacturing, Pfizer, solid-dose Leave a comment
Astellas and OSI Come Together
The months-long saga is finally over: Astellas’ enhanced offer of $57.50 a share—around $4 billion—has finally netted it Melville, NY-based OSI Pharmaceuticals.
The Japan-based pharma first extended an acquisition offer of $52 per share ($3.5 billion) to OSI on March 1, only to be met with a resounding “Nay” from the board, which said $52 [...]
TB Alliance Trumpets New, Improved Drugs at World Health Assembly
Like polio and leprosy, developed countries have long since tamed tuberculosis. But even now, other parts of the world continue to struggle against the disease, with nearly all (98 percent) of TB’s 1.7 million worldwide deaths occurring in developing countries. TB’s high comorbidity with HIV infections has recently added another level of urgency to efforts [...]

Novartis Employees Get $250 million Payout